A New Way to Treat High Cholesterol?
A New Way to Treat High Cholesterol?
“We haven’t really been able to get cholesterol down this low before," Jampolis says. "These drugs are very powerful, so these studies that are ongoing are going to be looking very closely at potential side effects from getting cholesterol too low.”
Though cholesterol is generally looked at as a bad thing, there are some functions in the body that use this substance for good, she says. For example, cholesterol molecules help convert sunlight on the skin into vitamin D, and it is a vital building block of our cells.
Too much cholesterol, though, can lead to plaque buildup in the arteries and heart disease.
What will they cost?
The price paid by wholesalers and distributors of Praluent is expected to be $1,120 for a 28-day supply, according to drug manufacturers Sanofi and Regeneron Pharmaceuticals. Patient costs are expected to be lower because of discounts and rebates, the companies say, and out-of-pocket costs will vary depending on insurance and whether a patient is eligible for assistance.
National pharmacy chain CVS Health estimated earlier that these drugs may cost between $7,000 and $12,000 for a year’s supply.
A New Way to Treat High Cholesterol?
“We haven’t really been able to get cholesterol down this low before," Jampolis says. "These drugs are very powerful, so these studies that are ongoing are going to be looking very closely at potential side effects from getting cholesterol too low.”
Though cholesterol is generally looked at as a bad thing, there are some functions in the body that use this substance for good, she says. For example, cholesterol molecules help convert sunlight on the skin into vitamin D, and it is a vital building block of our cells.
Too much cholesterol, though, can lead to plaque buildup in the arteries and heart disease.
What will they cost?
The price paid by wholesalers and distributors of Praluent is expected to be $1,120 for a 28-day supply, according to drug manufacturers Sanofi and Regeneron Pharmaceuticals. Patient costs are expected to be lower because of discounts and rebates, the companies say, and out-of-pocket costs will vary depending on insurance and whether a patient is eligible for assistance.
National pharmacy chain CVS Health estimated earlier that these drugs may cost between $7,000 and $12,000 for a year’s supply.
Source...